AQST Aquestive Therapeutics, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Wyświetl na SEC EDGAR ↗ 10-K/10-Q Sie 11, 2026
$4,17
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$3,1052tyg. minimum
$7,0552tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$523M
P/E (TTM)
-6.4
EPS (TTM)
$-0.65
Przychody (TTM)
$54M
Twoje odznaki
Zakres 52 tyg.
$3–$7
Ocena Analityków
BUY
Cena Docelowa
$9
P/E
-6.4
ROE
121.1%
Marża Zysku Netto
-144.6%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
AQST Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$4.17
Kapitalizacja Rynkowa (MRQ)
$523M
P/E (TTM)
-6.4
EPS (TTM)
$-0.65
Przychody (TTM)
$54M
ROE (TTM)
121.1%
Zakres 52 tyg.
$3–$7
AQST Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$45M2017-12-31 → 2025-12-31
EPS$-0.782020-12-31 → 2025-12-31
Wolny przepływ pieniężny$-53M2018-12-31 → 2025-12-31
Marża netto-144.6%2018-12-31 → 2025-12-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | AQST | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | -6.4średnia z 5 lat ≈-6.7 | ≈-6.7 | · | · | |
| P/S (TTM) | 9.7średnia z 5 lat ≈6.1 | ≈6.1 | 4.9 | Zawyżona wycena | |
| P/B (MRQ) | -9.2średnia z 5 lat ≈-6.5 | ≈-6.5 | · | · | |
| Cena / FCF (TTM) | -11.4średnia z 5 lat ≈-10.4 | ≈-10.4 | · | · | |
| Cena / Przepływy pieniężne (TTM) | -11.5średnia z 5 lat ≈-11.2 | ≈-11.2 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | AQST | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża Operacyjna (TTM) | -97.5%średnia z 5 lat ≈-79.9% | ≈-79.9% | -5.4% | Słaby | |
| EBITDA Margin (Marża EBITDA) | -159.5%średnia z 5 lat ≈-79.9% | ≈-79.9% | -5.3% | Słaby | |
| Marża przed opodatkowaniem (TTM) | -144.6%średnia z 5 lat ≈-106.5% | ≈-106.5% | 11.2% | Słaby | |
| Marża Zysku Netto (TTM) | -144.6%średnia z 5 lat ≈-106.6% | ≈-106.6% | -9.6% | Słaby | |
| ROA (TTM) | -69.3%średnia z 5 lat ≈-67.5% | ≈-67.5% | -20.8% | Słaby | |
| ROE (TTM) | 121.1%średnia z 5 lat ≈79.2% | ≈79.2% | 52.4% | Najwyższa półka | |
| ROIC | 211.1%średnia z 5 lat ≈70.9% | ≈70.9% | 40.3% | Najwyższa półka |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | AQST | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Wskaźnik bieżący (MRQ) | 7.2średnia z 5 lat ≈2.6 | ≈2.6 | 3.5 | Silna płynność | |
| Quick Ratio (Wskaźnik Szybkości) | 0.4 | · | 2.2 | Silna płynność |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | AQST | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | -22.6%średnia z 5 lat ≈0.39% | ≈0.39% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | -2.2%średnia z 5 lat ≈1.8% | ≈1.8% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | -0.58% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | AQST | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.3średnia z 5 lat ≈0.7 | ≈0.7 | 0.5 | Słaby | |
| Inventory Turnover (Rotacja zapasów) | 3.0średnia z 5 lat ≈3.0 | ≈3.0 | 1.2 | Najwyższa półka | |
| Receivables Turnover (Rotacja należności) | 3.5 | · | 4.5 | Słaby | |
| Revenue / Employee (Przychody / pracownika) | ≈$303.0K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
6.6%
Następny raport
Lis 03, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Sie 11, 2026 | $-0.08 | $-0.11 | 24.1% |
| 31 marca 2026 | Maj 13, 2026 | $-0.07 | $-0.14 | 50.0% |
| 31 grudnia 2025 | $-0.15 | $-0.14 | -10.9% | |
| 30 września 2025 | $-0.14 | $-0.14 | -3.6% | |
| 30 czerwca 2025 | $-0.14 | $-0.17 | 18.5% | |
| 31 marca 2025 | $-0.24 | $-0.17 | -38.4% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $45M | $58M | $51M | $48M | $51M | $46M | $53M | $67M | $67M | |
| Cost of Revenue | $19M | $18M | $21M | $19M | · | $13M | $20M | · | · | |
| R&D Expense | $17M | $20M | $13M | $17M | $17M | $20M | $21M | $23M | $22M | |
| SG&A Expense | $80M | $50M | $32M | $53M | $53M | $56M | $64M | $72M | $25M | |
| Operating Expenses | $116M | $88M | $66M | $90M | $86M | $89M | $105M | $116M | $67M | |
| Operating Income | $-71M | $-31M | $-15M | $-42M | $-35M | $-43M | $-53M | $-49M | $-113.0K | |
| Interest Expense | · | · | $6M | $7M | $10M | $11M | $9M | $8M | $8M | |
| Interest Income | · | · | · | · | · | $132.0K | $636.0K | · | · | |
| Pretax Income | $-84M | $-44M | $-8M | $-54M | $-71M | $-56M | $-66M | $-61M | $-9M | |
| Income Tax | $0 | $-14.0K | $245.0K | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-84M | $-44M | $-8M | $-54M | $-71M | $-56M | $-66M | $-61M | $-9M | |
| EPS (Basic) | $-0.78 | $-0.51 | $-0.13 | $-1.12 | $-1.85 | $-1.66 | · | · | · | |
| EPS (Diluted) | $-0.78 | $-0.51 | $-0.13 | $-1.12 | $-1.85 | $-1.66 | · | · | · | |
| Shares (Basic) | 106,926,528 | 86,726,211 | 61,255,864 | 48,734,377 | 38,077,660 | 33,651,127 | · | · | · | |
| Shares (Diluted) | 106,926,528 | 86,726,211 | 61,255,864 | 48,734,377 | 38,077,660 | 33,651,127 | · | · | · | |
| EBITDA | $-71M | $-31M | $-15M | $-42M | $-35M | $-43M | $-53M | $-46M | · |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $121M | $72M | $24M | $27M | $28M | $32M | $49M | $61M | $17M | |
| Receivables | $18M | $7M | $8M | · | · | · | · | · | $6M | |
| Inventory | $6M | $6M | $7M | $6M | $4M | $2M | $3M | $5M | $4M | |
| Prepaid Expense | $4M | $3M | $2M | $2M | $3M | $3M | $3M | $2M | $591.0K | |
| Current Assets | $149M | $88M | $41M | $40M | $47M | $45M | $68M | $74M | $28M | |
| PP&E (Net) | $4M | $4M | $4M | $4M | $5M | $7M | $10M | $12M | $13M | |
| PP&E (Gross) | $48M | $47M | $47M | $46M | $45M | $48M | $48M | $47M | $45M | |
| Accum. Depreciation | $44M | $44M | $43M | $42M | $40M | $41M | $38M | $35M | $32M | |
| Intangibles | $0 | $0 | $1M | $1M | $51.0K | $102.0K | $153.0K | $204.0K | $254.0K | |
| Other Non-current Assets | $3M | $4M | $5M | $6M | $7M | $8M | $286.0K | $239.0K | $1M | |
| Total Assets | $160M | $101M | $57M | $57M | $62M | $63M | $78M | $87M | $43M | |
| Accounts Payable | $30M | $10M | $9M | $10M | $8M | $7M | $12M | $20M | $10M | |
| Accrued Liabilities | $5M | $6M | $6M | $8M | $9M | $9M | $5M | $7M | $4M | |
| Current Liabilities | $48M | $19M | $18M | $40M | $22M | $21M | $19M | $33M | $15M | |
| Capital Leases | $4M | $5M | $5M | $5M | $2M | $3M | $0 | · | · | |
| Other Non-current Liabilities | $7M | $2M | $2M | $2M | $2M | $2M | $1M | · | · | |
| Total Liabilities | $194M | $162M | $164M | $176M | $144M | $111M | $85M | $77M | $70M | |
| Long-term Debt | $45M | $45M | $45M | · | · | $52M | $70M | · | · | |
| Common Stock | $122.0K | $91.0K | $69.0K | $55.0K | $41.0K | $35.0K | $34.0K | $25.0K | $0 | |
| Paid-in Capital | $413M | $303M | $213M | $193M | $175M | $138M | $124M | $71M | $0 | |
| Retained Earnings | $-447M | $-363M | $-319M | $-311M | $-257M | $-186M | $-130M | $-61M | $-120M | |
| Stockholders' Equity | $-34M | $-60M | $-106M | $-119M | $-82M | $-48M | $-6M | $10M | $-26M | |
| Liabilities + Equity | $160M | $101M | $57M | $57M | $62M | $63M | $78M | $87M | $43M | |
| Shares Outstanding | 122,044,299 | 91,413,742 | 68,533,085 | 54,827,734 | 41,228,736 | 34,569,254 | 33,562,885 | 24,957,309 | · |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $548.0K | $718.0K | $1M | $2M | $3M | $3M | $3M | $3M | $4M | |
| Stock-based Comp | $8M | $7M | $3M | $4M | $7M | $7M | $7M | $30M | $0 | |
| Deferred Tax | $0 | $0 | $0 | $0 | · | · | · | · | · | |
| Amort. of Intangibles | $0 | $78.0K | $157.0K | $116.0K | $51.0K | $51.0K | $50.0K | $50.0K | $51.0K | |
| Other Non-cash | · | · | · | · | · | · | · | $15M | · | |
| Operating Cash Flow | $-52M | $-36M | $-6M | $-10M | $-33M | $-45M | $-60M | $-13M | $6M | |
| CapEx | $562.0K | $159.0K | $995.0K | $1M | $913.0K | $517.0K | $663.0K | $2M | $2M | |
| Investing Cash Flow | $-562.0K | $-159.0K | $-995.0K | $-3M | $-913.0K | $-517.0K | $-663.0K | $-2M | $-2M | |
| Financing Cash Flow | $103M | $84M | $4M | $12M | $30M | $28M | $50M | $58M | $4M | |
| Net Change in Cash | $50M | $48M | $-3M | $-751.0K | $-4M | $-18M | · | $43M | $8M | |
| Taxes Paid | $0 | $305.0K | $0 | · | · | · | · | · | · | |
| Free Cash Flow | $-53M | $-36M | $-7M | $-11M | $-34M | $-46M | $-61M | $-15M | · | |
| Levered FCF | · | · | $-14M | $-17M | $-44M | $-57M | $-70M | $-23M | · |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -159.5% | -53.5% | -29.9% | -88.2% | -68.2% | -93.5% | -100.1% | -72.6% | · | |
| Net Margin | -188.1% | -76.7% | -15.6% | -114.1% | -138.8% | -121.7% | -125.9% | -91.0% | · | |
| Pretax Margin | -188.1% | -76.7% | -15.1% | -114.1% | -138.8% | -121.7% | -125.9% | -91.0% | · | |
| EBITDA Margin | -159.5% | -53.5% | -29.9% | -88.2% | -68.2% | -93.5% | -100.1% | -67.8% | · | |
| ROA | -64.0% | -55.6% | -13.8% | -91.4% | -113.0% | -78.9% | -80.1% | -94.5% | · | |
| ROE | 157.7% | 83.6% | 7.5% | 48.1% | 99.0% | 131.2% | 326.5% | -366.2% | · | |
| ROIC | 211.1% | 51.1% | 14.6% | 35.5% | 42.2% | 88.4% | 860.3% | -485.5% | · |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | 4.7 | 2.2 | 1.0 | 2.2 | 2.1 | 3.7 | 2.3 | · | |
| Quick Ratio | 0.4 | 0.4 | · | · | · | 1.5 | 2.7 | 1.8 | · | |
| Interest Coverage | · | · | -2.4 | -6.4 | -3.5 | -3.9 | -5.7 | -6.3 | · |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.7 | 0.9 | 0.8 | 0.8 | 0.6 | 0.6 | 1.0 | · | |
| Inventory Turnover | 3.0 | 2.8 | 3.3 | · | · | 4.9 | · | · | · | |
| Receivables Turnover | 3.5 | 7.3 | · | · | · | · | · | · | · |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.28 | $-0.66 | $-1.55 | $-2.16 | $-1.99 | $-1.40 | $-0.18 | $0.40 | · | |
| Revenue / Share | $0.42 | $0.66 | $0.83 | $0.98 | $1.33 | · | · | · | · | |
| Cash Flow / Share | $-0.49 | $-0.41 | $-0.10 | $-0.20 | $-0.87 | · | · | · | · | |
| Cash / Share | · | · | · | · | · | $0.92 | $1.47 | $2.43 | · | |
| EPS (TTM) | $-0.78 | $-0.51 | $-0.13 | $-1.12 | $-1.85 | $-1.66 | · | · | · |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -22.6% | 13.8% | 6.1% | -6.2% | 10.9% | · | · | · | · | |
| Revenue CAGR 3Y | -2.2% | 4.2% | 3.3% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -0.58% | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $45M | $58M | $51M | $48M | $51M | $46M | $53M | $67M | · | |
| Net Income TTM | $-84M | $-44M | $-8M | $-54M | $-71M | $-56M | $-66M | $-61M | · | |
| Market Cap | $788M | $325M | $138M | $49M | $160M | $185M | $195M | $157M | · | |
| P/E | -8.3 | -7.0 | -15.5 | -0.8 | -2.1 | -3.2 | · | · | · | |
| P/S | 17.7 | 5.7 | 2.7 | 1.0 | 3.2 | 4.0 | 3.7 | 2.3 | · | |
| P/B | -23.4 | -5.4 | -1.3 | -0.4 | -2.0 | -3.8 | -31.9 | 15.6 | · | |
| P / Cash Flow | -15.0 | -9.1 | -21.7 | -5.1 | -4.9 | -4.1 | -3.2 | -12.1 | · | |
| P / FCF | -14.9 | -9.1 | -18.8 | -4.6 | -4.7 | -4.0 | -3.2 | -10.6 | · | |
| Earnings Yield | -12.1% | -14.3% | -6.4% | -124.2% | -47.6% | -31.0% | · | · | · |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14M | $14M | $13M | $13M | $10M | $9M | $12M | $14M | $20M | $12M | $13M | $13M | $13M | $11M | $11M | $11M | |
| Cost of Revenue | $4M | $3M | $6M | $5M | $5M | $4M | $5M | $4M | $5M | $4M | $5M | $5M | $7M | $5M | $5M | $5M | |
| R&D Expense | $4M | $4M | $3M | $5M | $4M | $5M | $5M | $5M | $4M | $6M | $3M | $3M | $3M | $4M | $4M | $3M | |
| SG&A Expense | $14M | $11M | $33M | $15M | $13M | $19M | $16M | $12M | $11M | $11M | $10M | $7M | $7M | $7M | $12M | $12M | |
| Operating Expenses | $22M | $19M | $42M | $24M | $21M | $28M | $25M | $22M | $20M | $21M | $17M | $15M | $17M | $16M | $21M | $20M | |
| Operating Income | $-8M | $-4M | $-29M | $-11M | $-11M | $-19M | $-14M | $-8M | $55.0K | $-9M | $-4M | $-2M | $-4M | $-5M | $-11M | $-9M | |
| Interest Expense | · | · | · | · | · | · | · | · | $3M | $3M | · | $1M | $1M | $1M | $2M | $2M | |
| Pretax Income | $-23M | $-8M | $-32M | $-15M | $-14M | $-23M | $-17M | $-12M | $-3M | $-13M | $-8M | $-2M | $-6M | $8M | $-12M | $-13M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $-14.0K | $0 | $0 | $0 | $101.0K | $-140.0K | $284.0K | $0 | $0 | $0 | |
| Net Income | $-23M | $-8M | $-32M | $-15M | $-14M | $-23M | $-17M | $-12M | $-3M | $-13M | $-8M | $-2M | $-6M | $8M | $-12M | $-13M | |
| EPS (Basic) | $-0.18 | $-0.07 | $-0.26 | $-0.14 | $-0.14 | $-0.24 | $-0.18 | $-0.13 | $-0.03 | $-0.17 | $-0.15 | $-0.03 | $-0.10 | $0.15 | $-0.21 | $-0.23 | |
| EPS (Diluted) | $-0.18 | $-0.07 | $-0.26 | $-0.14 | $-0.14 | $-0.24 | $-0.18 | $-0.13 | $-0.03 | $-0.17 | $-0.11 | $-0.03 | $-0.10 | $0.11 | $-0.21 | $-0.23 | |
| Shares (Basic) | 124,994,165 | 122,609,995 | · | 110,584,371 | 99,326,701 | 95,497,056 | · | 91,082,081 | 90,911,626 | 73,614,710 | · | 64,678,761 | 57,350,902 | 55,631,947 | · | 53,424,922 | |
| Shares (Diluted) | 124,994,165 | 122,609,995 | · | 110,584,371 | 99,326,701 | 95,497,056 | · | 91,082,081 | 90,911,626 | 73,614,710 | · | 64,678,761 | 57,350,902 | 73,792,886 | · | 53,424,922 | |
| EBITDA | $-8M | $-4M | · | $-11M | $-11M | $-19M | · | $-8M | $55.0K | $-9M | · | $-2M | $-4M | $-5M | · | $-9M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $98M | $111M | · | $129M | $61M | $69M | · | $78M | $90M | $95M | · | $25M | $22M | $27M | · | $19M | |
| Receivables | $9M | $7M | $18M | · | · | · | $7M | · | · | · | $8M | · | · | · | · | · | |
| Inventory | $7M | $8M | $6M | $8M | $8M | $7M | $6M | $7M | $7M | $8M | $7M | $7M | $6M | $7M | $6M | $7M | |
| Prepaid Expense | $3M | $5M | $4M | $3M | $1M | $3M | $3M | $2M | $1M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | |
| Current Assets | $118M | $130M | $149M | $152M | $82M | $89M | $88M | $97M | $104M | $113M | $41M | $42M | $40M | $44M | $40M | $38M | |
| PP&E (Net) | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $4M | $4M | $4M | |
| PP&E (Gross) | $48M | $48M | $48M | $48M | $48M | $47M | $47M | $47M | $47M | $47M | $47M | $47M | $47M | $46M | $46M | $46M | |
| Accum. Depreciation | $44M | $44M | $44M | $44M | $44M | $44M | $44M | $43M | $43M | $43M | $43M | $43M | $42M | $42M | $42M | $42M | |
| Intangibles | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Other Non-current Assets | $2M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | |
| Total Assets | $132M | $141M | $160M | $164M | $94M | $102M | $101M | $110M | $118M | $130M | $57M | $59M | $57M | $61M | $57M | $52M | |
| Accounts Payable | $9M | $12M | $30M | $11M | $12M | $12M | $10M | $8M | $6M | $11M | $9M | $10M | $11M | $12M | $10M | $11M | |
| Accrued Liabilities | $5M | $3M | $5M | $5M | $5M | $3M | $6M | $5M | $6M | $5M | $6M | $5M | $4M | $5M | $8M | $8M | |
| Current Liabilities | $16M | $32M | $48M | $26M | $23M | $18M | $19M | $15M | $14M | $18M | $18M | $24M | $39M | $40M | $40M | $37M | |
| Capital Leases | $8M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | $5M | $1M | |
| Other Non-current Liabilities | $6M | $6M | $7M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Total Liabilities | $189M | $175M | $194M | $168M | $166M | $163M | $162M | $155M | $153M | $166M | $164M | $162M | $164M | $171M | $176M | $160M | |
| Long-term Debt | $55M | $45M | $45M | $45M | $45M | $45M | · | $45M | $45M | $45M | · | $39M | $39M | $42M | · | $52M | |
| Common Stock | $126.0K | $124.0K | $122.0K | $121.0K | $99.0K | $99.0K | $91.0K | $91.0K | $91.0K | $90.0K | $69.0K | $67.0K | $62.0K | $56.0K | $55.0K | $54.0K | |
| Paid-in Capital | $421M | $421M | $413M | $411M | $327M | $325M | $303M | $301M | $299M | $296M | $213M | $208M | $202M | $194M | $193M | $191M | |
| Retained Earnings | $-478M | $-455M | $-447M | $-415M | $-400M | $-386M | $-363M | $-346M | $-335M | $-332M | $-319M | $-311M | $-309M | $-303M | $-311M | $-299M | |
| Stockholders' Equity | $-57M | $-34M | $-34M | $-4M | $-73M | $-61M | $-60M | $-45M | $-35M | $-36M | $-106M | $-103M | $-107M | $-109M | $-119M | $-108M | |
| Liabilities + Equity | $132M | $141M | $160M | $164M | $94M | $102M | $101M | $110M | $118M | $130M | $57M | $59M | $57M | $61M | $57M | $52M | |
| Shares Outstanding | 125,511,648 | 124,284,542 | 122,044,299 | 121,658,113 | 99,353,270 | 99,317,153 | 91,413,742 | 91,178,193 | 91,059,760 | 90,478,731 | 68,533,085 | 66,740,765 | 61,615,959 | 55,922,361 | 54,827,734 | 53,852,126 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $136.0K | $113.0K | $130.0K | $139.0K | $140.0K | $139.0K | $147.0K | $159.0K | $205.0K | $207.0K | $467.0K | $264.0K | $289.0K | $325.0K | $397.0K | $596.0K | |
| Stock-based Comp | $3M | $2M | $1M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $940.0K | $774.0K | $631.0K | $344.0K | $714.0K | $535.0K | |
| Amort. of Intangibles | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $39.0K | $39.0K | $40.0K | $39.0K | $39.0K | $39.0K | $51.0K | $39.0K | |
| Operating Cash Flow | $-9M | $-15M | $-8M | $-13M | $-8M | $-23M | $-6M | $-12M | $-7M | $-10M | $-5M | $-2M | $-8M | $9M | $8M | $3M | |
| CapEx | $212.0K | $52.0K | $85.0K | $235.0K | $107.0K | $135.0K | $15.0K | $80.0K | $35.0K | $29.0K | $16.0K | $151.0K | $826.0K | $2.0K | $26.0K | $217.0K | |
| Investing Cash Flow | $-212.0K | $-52.0K | $-85.0K | $-235.0K | $-107.0K | $-135.0K | $-15.0K | $-80.0K | $-35.0K | $-29.0K | $-16.0K | $-151.0K | $-826.0K | $-2.0K | $-26.0K | $-2M | |
| Financing Cash Flow | $-3M | $4M | $660.0K | $81M | $-100.0K | $21M | $157.0K | $-17.0K | $2M | $82M | $4M | $5M | $4M | $-9M | $234.0K | $-138.0K | |
| Net Change in Cash | $-12M | $-10M | $-8M | $69M | $-8M | $-3M | $-6M | $-12M | $-5M | $71M | $-1M | $2M | $-4M | $-391.0K | $9M | $954.0K | |
| Taxes Paid | · | · | $0 | $0 | $-2M | $2M | $0 | $0 | $-698.0K | $1M | $0 | $0 | · | · | · | · | |
| Free Cash Flow | · | $-15M | · | · | · | $-24M | · | · | · | $-10M | · | · | · | $9M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-13M | · | · | · | $7M | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -59.5% | -29.1% | · | -89.6% | -113.7% | -222.1% | · | -61.2% | 0.27% | -74.3% | · | -18.3% | -31.8% | -41.4% | · | -77.2% | |
| Net Margin | -165.5% | -55.8% | · | -120.6% | -135.4% | -263.0% | · | -85.0% | -13.7% | -106.4% | · | -15.7% | -43.7% | 72.5% | · | -109.4% | |
| Pretax Margin | -165.5% | -55.8% | · | -120.6% | -135.4% | -263.0% | · | -85.0% | -13.7% | -106.4% | · | -16.7% | -41.6% | 72.5% | · | -109.4% | |
| EBITDA Margin | -59.5% | -29.1% | · | -89.6% | -113.7% | -222.1% | · | -61.2% | 0.27% | -74.3% | · | -18.3% | -31.8% | -41.4% | · | -77.2% | |
| ROA | -20.2% | -6.6% | · | -11.3% | -12.8% | -19.8% | · | -13.6% | -3.1% | -13.5% | · | -3.7% | -10.2% | 13.7% | · | -21.4% | |
| ROE | 35.4% | 17.0% | · | 62.4% | 25.1% | 47.2% | · | 15.5% | 3.9% | 17.6% | · | 1.9% | 5.7% | -8.0% | · | 14.9% | |
| ROIC | 14.5% | 12.3% | · | 279.4% | 15.7% | 31.8% | · | 18.2% | -0.16% | 24.7% | · | 2.2% | 4.2% | 4.2% | · | 8.2% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.2 | 4.1 | · | 5.9 | 3.5 | 4.9 | · | 6.4 | 7.5 | 6.3 | · | 1.8 | 1.0 | 1.1 | · | 1.0 | |
| Quick Ratio | 6.5 | 3.7 | · | 5.0 | 2.6 | 3.8 | · | 5.1 | 6.5 | 5.3 | · | 1.0 | 0.6 | 0.7 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | 0.0 | -3.2 | · | -1.9 | -3.1 | -3.2 | · | -5.4 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.5 | · | 0.6 | 0.7 | 0.6 | · | 0.7 | 1.2 | 0.8 | · | 1.0 | |
| Receivables Turnover | 1.7 | 4.2 | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.45 | $-0.27 | · | $-0.03 | $-0.73 | $-0.61 | · | $-0.50 | $-0.39 | $-0.40 | · | $-1.54 | $-1.73 | $-1.95 | · | $-2.00 | |
| Revenue / Share | $0.11 | $0.12 | · | $0.12 | $0.10 | $0.09 | · | $0.15 | $0.22 | $0.16 | · | $0.20 | $0.23 | $0.15 | · | $0.21 | |
| Cash Flow / Share | · | $-0.12 | · | · | · | $-0.24 | · | · | · | $-0.14 | · | · | · | $0.12 | · | · | |
| Cash / Share | $0.78 | $0.89 | · | $1.06 | $0.61 | $0.69 | · | $0.85 | $0.99 | $1.05 | · | $0.37 | $0.36 | $0.48 | · | $0.35 | |
| EPS (TTM) | $-0.65 | $-0.61 | · | $-0.70 | $-0.69 | $-0.58 | · | $-0.44 | $-0.34 | $-0.41 | · | $-0.23 | $-0.43 | $-0.69 | · | $-1.65 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $54M | $50M | · | $43M | $44M | $54M | · | $59M | $58M | $52M | · | $48M | $47M | $47M | · | $48M | |
| Net Income TTM | $-78M | $-69M | · | $-69M | $-65M | $-54M | · | $-35M | $-26M | $-29M | · | $-12M | $-23M | $-33M | · | $-71M | |
| Market Cap | $522M | $516M | · | $680M | $329M | $288M | · | $454M | $237M | $385M | · | $102M | $102M | $64M | · | $63M | |
| P/E | -6.4 | -6.8 | · | -8.0 | -4.8 | -5.0 | · | -11.3 | -7.6 | -10.4 | · | -6.7 | -3.8 | -1.7 | · | -0.7 | |
| P/S | 9.7 | 10.3 | · | 15.7 | 7.5 | 5.3 | · | 7.7 | 4.1 | 7.5 | · | 2.1 | 2.2 | 1.4 | · | 1.3 | |
| P/B | -9.2 | -15.1 | · | -165.5 | -4.5 | -4.7 | · | -10.0 | -6.7 | -10.6 | · | -1.0 | -1.0 | -0.6 | · | -0.6 | |
| P / Cash Flow | · | -34.8 | · | · | · | -12.3 | · | · | · | -37.1 | · | · | · | 7.2 | · | · | |
| Earnings Yield | -15.6% | -14.7% | · | -12.5% | -20.8% | -20.0% | · | -8.8% | -13.1% | -9.6% | · | -15.0% | -26.1% | -60.5% | · | -141.0% |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $45M | $58M | $51M | $48M | $51M |
| Marża Operacyjna % | -159.5% | -53.5% | -29.9% | -88.2% | -68.2% |
| Zysk netto | $-84M | $-44M | $-8M | $-54M | $-71M |
| Rozwodniony EPS | $-0.78 | $-0.51 | $-0.13 | $-1.12 | $-1.85 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 3.1 | 4.7 | 2.2 | 1.0 | 2.2 |
| Wskaźnik Szybkości | 0.4 | 0.4 | · | · | · |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-53M | $-36M | $-7M | $-11M | $-34M |
Właściciele instytucjonalni (13F) 195 emitentów · $337.4M łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
195
Wartość posiadanych akcji
$337.4M
Nowe pozycje
26
Zamknięte pozycje
18
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 26 (-23 vs poprzedni kw.) | 18 (-29 vs poprzedni kw.) | 69 (+10 vs poprzedni kw.) | 49 (0 vs poprzedni kw.) | +154K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| Bratton Capital Management, L.P. | $40 813 585 | 9 810 958 | 12,10% | Akcje |
| VANGUARD GROUP INC | $38 064 478 | 5 892 334 | 11,28% | Akcje |
| BlackRock, Inc. | $33 568 590 | 8 069 373 | 9,95% | Akcje |
| RTW INVESTMENTS, LP | $30 894 119 | 7 426 471 | 9,16% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $19 071 657 | 4 584 533 | 5,65% | Akcje |
| FEDERATED HERMES, INC. | $12 948 253 | 3 112 561 | 3,84% | Akcje |
| STATE STREET CORP | $12 180 563 | 2 928 020 | 3,61% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $10 913 743 | 2 622 888 | 3,23% | Akcje |
| SAMSARA BIOCAPITAL, LLC | $10 400 000 | 2 500 000 | 3,08% | Akcje |
| BANK OF AMERICA CORP /DE/ | $6 940 640 | 1 668 423 | 2,06% | Akcje |
| Sio Capital Management, LLC | $6 182 488 | 1 486 175 | 1,83% | Akcje |
| Propel Bio Management, LLC | $6 000 372 | 1 442 397 | 1,78% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $5 329 904 | 1 281 227 | 1,58% | Akcje |
| Nuveen, LLC | $5 055 336 | 1 215 225 | 1,50% | Akcje |
| WELLS FARGO & COMPANY/MN | $4 530 394 | 1 089 037 | 1,34% | Akcje |
| COMMONWEALTH EQUITY SERVICES, LLC | $4 352 090 | 1 046 175 | 1,29% | Akcje |
| BARCLAYS PLC | $4 146 126 | 996 665 | 1,23% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3 951 168 | 949 800 | 1,17% | Opcja kupna |
| Blue Owl Capital Holdings LP | $3 922 597 | 942 932 | 1,16% | Akcje |
| NORTHERN TRUST CORP | $3 457 589 | 831 151 | 1,02% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $3 305 902 | 794 688 | 0,98% | Akcje |
| Balyasny Asset Management L.P. | $3 097 270 | 744 536 | 0,92% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3 054 459 | 734 245 | 0,91% | Akcje |
| WASATCH ADVISORS LP | $3 001 041 | 648 173 | 0,89% | Akcje |
| MORGAN STANLEY | $2 739 848 | 658 617 | 0,81% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $2 709 038 | 651 211 | 0,80% | Akcje |
| DAFNA Capital Management LLC | $2 687 006 | 645 915 | 0,80% | Akcje |
| Everstar Asset Management, LLC | $2 545 683 | 611 943 | 0,75% | Akcje |
| TWO SIGMA ADVISERS, LP | $2 147 304 | 332 400 | 0,64% | Akcje |
| AWM Investment Company, Inc. | $1 977 664 | 475 400 | 0,59% | Akcje |
| GOLDMAN SACHS GROUP INC | $1 949 247 | 468 569 | 0,58% | Akcje |
| Bracebridge Capital, LLC | $1 910 339 | 459 216 | 0,57% | Akcje |
| UBS Group AG | $1 907 002 | 458 414 | 0,57% | Akcje |
| CITADEL ADVISORS LLC | $1 881 140 | 452 197 | 0,56% | Akcje |
| JANE STREET GROUP, LLC | $1 819 958 | 437 490 | 0,54% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $1 731 592 | 416 248 | 0,51% | Akcje |
| STIFEL FINANCIAL CORP | $1 505 516 | 361 903 | 0,45% | Akcje |
| Man Group plc | $1 463 072 | 351 700 | 0,43% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 286 272 | 309 200 | 0,38% | Opcja sprzedaży |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1 274 599 | 306 394 | 0,38% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $1 254 852 | 301 647 | 0,37% | Akcje |
| MARSHALL WACE, LLP | $1 188 340 | 285 659 | 0,35% | Akcje |
| Walleye Capital LLC | $1 175 483 | 282 568 | 0,35% | Akcje |
| Simplify Asset Management Inc. | $1 159 488 | 278 723 | 0,34% | Akcje |
| Bank of New York Mellon Corp | $1 146 264 | 275 544 | 0,34% | Akcje |
| Russell Investments Group, Ltd. | $1 083 599 | 260 481 | 0,32% | Akcje |
| Rosalind Advisors, Inc. | $1 040 000 | 250 000 | 0,31% | Akcje |
| Latash Investments, LLC | $1 011 437 | 243 134 | 0,30% | Akcje |
| Hudson Bay Capital Management LP | $973 440 | 234 000 | 0,29% | Akcje |
| Lido Advisors, LLC | $895 715 | 215 316 | 0,27% | Akcje |
Insiderzy spółki 29 insiderów · 19 dyrektorzy generalni · 11 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Daniel Barber | President and CEO | 15 października 2026 S | 627 317 | 0 | 8 | $-1 326 235 |
| Keith J Kendall | CEO and President | 10 marca 2022 A | 1 000 | 0 | 0 | $0 |
| Ernest A Toth JR | Chief Financial Officer | 5 maja 2026 F | 283 460 | 0 | 1 | $-242 919 |
| John T. Maxwell | SVP-Chief Financial Officer | 18 sierpnia 2020 S | 150 614 | 0 | 0 | $0 |
| Cassie Jung | Chief Operating Officer | 3 września 2026 X | 206 833 | 0 | 1 | $-190 948 |
| Sherry Korczynski | Chief Commercial Officer | 9 września 2026 M | 235 689 | 0 | 2 | $-111 315 |
| Peter E. Boyd | Chief People Officer | 9 września 2026 X | 284 024 | 0 | 1 | $-124 324 |
| Thomas A. Zalewski | Chief Legal Officer | 18 maja 2026 A | 100 000 | 0 | 0 | $0 |
| Melina Cioffi | SVP, Regulatory Affairs | 15 maja 2026 F | 273 200 | 0 | 1 | $-105 547 |
| Lori J Braender | Corporate Secretary | 7 maja 2026 F | 231 042 | 0 | 1 | $-167 225 |
| Matthew J. Greenhawt | Chief Medical Officer | 9 marca 2026 A | 75 000 | 0 | 0 | $0 |
| Matthew W. Davis | Chief Development Officer | 9 marca 2026 A | 100 000 | 0 | 0 | $0 |
| Carl N Kraus | Chief Medical Officer | 15 października 2025 S | 282 475 | 0 | 0 | $0 |
| Stephen Wargacki | Chief Science Officer | 7 marca 2025 A | 343 552 | 0 | 0 | $0 |
| Alexander Mark Schobel | Chief Innovation/Tech Officer | 9 marca 2024 F | 980 726 | 0 | 0 | $0 |
| Ken W. Marshall | SVP, Chief Commercial Officer | 9 sierpnia 2023 A | 150 000 | 0 | 0 | $0 |
| Kenneth Truitt | Chief Medical Officer | 6 września 2022 A | · | 0 | 0 | $0 |
| Theresa Wood | SVP-HR and Org. Development | 10 marca 2022 A | 80 765 | 0 | 0 | $0 |
| Gary H Slatko | SVP, Chief Medical Officer | 16 marca 2020 A | · | 0 | 0 | $0 |
| John Cochran | Dyrektor | 21 października 2026 J | 161 715 | 0 | 0 | $0 |
| Julie Krop | Dyrektor | 23 czerwca 2026 M | 0 | 0 | 1 | $-125 500 |
| Abigail L. Jenkins | Dyrektor | 10 czerwca 2026 A | · | 0 | 0 | $0 |
| Marco Taglietti | Dyrektor | 10 czerwca 2026 A | · | 0 | 0 | $0 |
| Gregory B Brown | Dyrektor | 10 czerwca 2026 A | · | 0 | 0 | $0 |
| Timothy E Morris | Dyrektor | 10 czerwca 2026 A | · | 0 | 0 | $0 |
| COSTA SANTO J | Dyrektor | 20 czerwca 2024 A | · | 0 | 0 | $0 |
| Nancy Lurker | Dyrektor | 15 czerwca 2021 A | · | 0 | 0 | $0 |
| James S Scibetta | Dyrektor | 15 czerwca 2021 A | 31 635 | 0 | 0 | $0 |
| Douglas K Bratton | Posiadacz 10% | 2 grudnia 2024 G | 199 841 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 16 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 0,51% | 28 299 NS | 31 lipca 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,46% | 22 601 SH | 23 października 2026 | Dziennie |
| IWC · iShares Trust | 0,13% | 367 240 SH | 11 września 2026 | Dziennie |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,03% | 9 531 SH | 23 października 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 59 348 SH | 19 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | 0,02% | 2 767 037 SH | 11 września 2026 | Dziennie |
| IWO · iShares Trust | 0,01% | 374 338 SH | 11 września 2026 | Dziennie |
| RSSL · Global X Funds | 0,01% | 51 582 NS | 31 lipca 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 621 390 SH | 19 sierpnia 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 43 284 SH | 19 sierpnia 2026 | Dziennie |
| ITOT · iShares Trust | 0,00% | 165 523 SH | 11 września 2026 | Dziennie |
| IWV · iShares Trust | 0,00% | 34 314 SH | 11 września 2026 | Dziennie |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 1 077 349 SH | 19 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3 403 709 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 10 223 SH | 19 sierpnia 2026 | Dziennie |
| IWN · iShares Trust | · | 638 760 SH | 11 września 2026 | Dziennie |
AQST Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 15 analityków
KUP
Średni cel
$10.00
+140,1%
4 26,7%
Mocne kupno
10 66,7%
Kup
1 6,7%
Trzymaj
0 0,0%
Sprzedaj
0 0,0%
Mocna sprzedaż
12-miesięczny cel cenowy
9 analityków · 2026-10-25Średnia cel $9.33 +124,1%
← Poniżej wszystkich celów
Aktualna cena $4.17
Niski$6.00
Średnia$9.33
Wysoki$11.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| AQST | $788M | -8.3 | -22.6% | -188.1% | 157.7% | · |
| CRMD | $922M | 5.7 | 617.0% | 52.3% | 52.1% | 88.5% |
| ZVRA | $509M | 6.6 | 350.9% | 78.2% | 61.2% | · |
| ACRS | $363M | -5.7 | -58.2% | -829.6% | -55.3% | · |
| PHAT | $1.18B | -5.5 | 216.9% | -126.4% | 52.4% | 87.1% |
| ARVN | $753M | -10.4 | -0.30% | -30.8% | -15.5% | · |
| EOLS | $432M | -8.3 | 11.6% | -17.4% | 247.3% | 66.3% |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Sie 11, 2026